Pixie Dust Technologies Sees FY24 Revenue 1.00 – 1.02 Billion Yen, Which Is An Increase Of 41.9%-44.7% From ~0.70 Billion Yen For The Fiscal Year Ended April 30, 2023.
$PXDT
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Business Outlook for FY2024
- Based on current expectations, unaudited and unreviewed total revenue is expected to be in the range of 1.00 – 1.02 billion yen, which is an increase of 41.9% to 44.7% from approximately 0.70 billion yen for the fiscal year ended April 30, 2023.